Metagenomic next-generation sequencing for mixed pulmonary infection diagnosis
Metagenomic next-generation sequencing (mNGS) is emerging as a promising technique for pathogens detection. However, reports on the application of mNGS in mixed pulmonary infection remain scarce. From July 2018 to March 2019, 55 cases were enrolled in this retrospective analysis. Cases were classifi...
Saved in:
| Published in | BMC pulmonary medicine Vol. 19; no. 1; pp. 252 - 8 |
|---|---|
| Main Authors | , , |
| Format | Journal Article |
| Language | English |
| Published |
England
BioMed Central Ltd
19.12.2019
BioMed Central BMC |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Metagenomic next-generation sequencing (mNGS) is emerging as a promising technique for pathogens detection. However, reports on the application of mNGS in mixed pulmonary infection remain scarce.
From July 2018 to March 2019, 55 cases were enrolled in this retrospective analysis. Cases were classified into mixed pulmonary infection (36 [65.5%]) and non-mixed pulmonary infection (19 [34.5%]) according to primary diagnoses. The performances of mNGS and conventional test on mixed pulmonary infection diagnosis and pathogen identification were compared.
The sensitivity of mNGS in mixed pulmonary infection diagnosis was much higher than that of conventional test (97.2% vs 13.9%; P < 0.01), but the specificity was the opposite (63.2% vs 94.7%; P = 0.07). The positive predictive value of mNGS was 83.3% (95% CI, 68.0-92.5%), and the negative predictive value was 92.3% (95% CI, 62.1-99.6%). A total of 5 (9.1%) cases were identified as mixed pulmonary infection by both conventional tests and mNGS, however, the pathogens identification results were consistent between these two methods in only 1 (1.8%) case. In summary, the pathogens detected by mNGS in 3 (5.5%) cases were consistent with those by conventional test, and only 1 (1.8%) case was mixed pulmonary infection. According to our data, mNGS had a broader spectrum for pathogen detection than conventional tests. In particular, application of mNGS improved the diagnosis of pulmonary fungal infections. Within the 55 cases, mNGS detected and identified fungi in 31 (56.4%) cases, of which only 10 (18.2%) cases were positive for the same fungi by conventional test. The most common pathogen detected by mNGS was Human cytomegalovirus in our study, which was identified in 19 (34.5%) cases of mixed pulmonary infection. Human cytomegalovirus and Pneumocystis jirovecii, which were detected in 7 (12.7%) cases, were the most common co-pathogens in the group of mixed pulmonary infection.
mNGS is a promising technique to detect co-pathogens in mixed pulmonary infection, with potential benefits in speed and sensitivity.
(retrospectively registered): ChiCTR1900023727. Registrated 9 JUNE 2019. |
|---|---|
| AbstractList | Abstract Background Metagenomic next-generation sequencing (mNGS) is emerging as a promising technique for pathogens detection. However, reports on the application of mNGS in mixed pulmonary infection remain scarce. Methods From July 2018 to March 2019, 55 cases were enrolled in this retrospective analysis. Cases were classified into mixed pulmonary infection (36 [65.5%]) and non-mixed pulmonary infection (19 [34.5%]) according to primary diagnoses. The performances of mNGS and conventional test on mixed pulmonary infection diagnosis and pathogen identification were compared. Results The sensitivity of mNGS in mixed pulmonary infection diagnosis was much higher than that of conventional test (97.2% vs 13.9%; P < 0.01), but the specificity was the opposite (63.2% vs 94.7%; P = 0.07). The positive predictive value of mNGS was 83.3% (95% CI, 68.0–92.5%), and the negative predictive value was 92.3% (95% CI, 62.1–99.6%). A total of 5 (9.1%) cases were identified as mixed pulmonary infection by both conventional tests and mNGS, however, the pathogens identification results were consistent between these two methods in only 1 (1.8%) case. In summary, the pathogens detected by mNGS in 3 (5.5%) cases were consistent with those by conventional test, and only 1 (1.8%) case was mixed pulmonary infection. According to our data, mNGS had a broader spectrum for pathogen detection than conventional tests. In particular, application of mNGS improved the diagnosis of pulmonary fungal infections. Within the 55 cases, mNGS detected and identified fungi in 31 (56.4%) cases, of which only 10 (18.2%) cases were positive for the same fungi by conventional test. The most common pathogen detected by mNGS was Human cytomegalovirus in our study, which was identified in 19 (34.5%) cases of mixed pulmonary infection. Human cytomegalovirus and Pneumocystis jirovecii, which were detected in 7 (12.7%) cases, were the most common co-pathogens in the group of mixed pulmonary infection. Conclusions mNGS is a promising technique to detect co-pathogens in mixed pulmonary infection, with potential benefits in speed and sensitivity. Trial registration (retrospectively registered): ChiCTR1900023727. Registrated 9 JUNE 2019. Background Metagenomic next-generation sequencing (mNGS) is emerging as a promising technique for pathogens detection. However, reports on the application of mNGS in mixed pulmonary infection remain scarce. Methods From July 2018 to March 2019, 55 cases were enrolled in this retrospective analysis. Cases were classified into mixed pulmonary infection (36 [65.5%]) and non-mixed pulmonary infection (19 [34.5%]) according to primary diagnoses. The performances of mNGS and conventional test on mixed pulmonary infection diagnosis and pathogen identification were compared. Results The sensitivity of mNGS in mixed pulmonary infection diagnosis was much higher than that of conventional test (97.2% vs 13.9%; P < 0.01), but the specificity was the opposite (63.2% vs 94.7%; P = 0.07). The positive predictive value of mNGS was 83.3% (95% CI, 68.0–92.5%), and the negative predictive value was 92.3% (95% CI, 62.1–99.6%). A total of 5 (9.1%) cases were identified as mixed pulmonary infection by both conventional tests and mNGS, however, the pathogens identification results were consistent between these two methods in only 1 (1.8%) case. In summary, the pathogens detected by mNGS in 3 (5.5%) cases were consistent with those by conventional test, and only 1 (1.8%) case was mixed pulmonary infection. According to our data, mNGS had a broader spectrum for pathogen detection than conventional tests. In particular, application of mNGS improved the diagnosis of pulmonary fungal infections. Within the 55 cases, mNGS detected and identified fungi in 31 (56.4%) cases, of which only 10 (18.2%) cases were positive for the same fungi by conventional test. The most common pathogen detected by mNGS was Human cytomegalovirus in our study, which was identified in 19 (34.5%) cases of mixed pulmonary infection. Human cytomegalovirus and Pneumocystis jirovecii, which were detected in 7 (12.7%) cases, were the most common co-pathogens in the group of mixed pulmonary infection. Conclusions mNGS is a promising technique to detect co-pathogens in mixed pulmonary infection, with potential benefits in speed and sensitivity. Trial registration (retrospectively registered): ChiCTR1900023727. Registrated 9 JUNE 2019. Metagenomic next-generation sequencing (mNGS) is emerging as a promising technique for pathogens detection. However, reports on the application of mNGS in mixed pulmonary infection remain scarce. From July 2018 to March 2019, 55 cases were enrolled in this retrospective analysis. Cases were classified into mixed pulmonary infection (36 [65.5%]) and non-mixed pulmonary infection (19 [34.5%]) according to primary diagnoses. The performances of mNGS and conventional test on mixed pulmonary infection diagnosis and pathogen identification were compared. The sensitivity of mNGS in mixed pulmonary infection diagnosis was much higher than that of conventional test (97.2% vs 13.9%; P < 0.01), but the specificity was the opposite (63.2% vs 94.7%; P = 0.07). The positive predictive value of mNGS was 83.3% (95% CI, 68.0-92.5%), and the negative predictive value was 92.3% (95% CI, 62.1-99.6%). A total of 5 (9.1%) cases were identified as mixed pulmonary infection by both conventional tests and mNGS, however, the pathogens identification results were consistent between these two methods in only 1 (1.8%) case. In summary, the pathogens detected by mNGS in 3 (5.5%) cases were consistent with those by conventional test, and only 1 (1.8%) case was mixed pulmonary infection. According to our data, mNGS had a broader spectrum for pathogen detection than conventional tests. In particular, application of mNGS improved the diagnosis of pulmonary fungal infections. Within the 55 cases, mNGS detected and identified fungi in 31 (56.4%) cases, of which only 10 (18.2%) cases were positive for the same fungi by conventional test. The most common pathogen detected by mNGS was Human cytomegalovirus in our study, which was identified in 19 (34.5%) cases of mixed pulmonary infection. Human cytomegalovirus and Pneumocystis jirovecii, which were detected in 7 (12.7%) cases, were the most common co-pathogens in the group of mixed pulmonary infection. mNGS is a promising technique to detect co-pathogens in mixed pulmonary infection, with potential benefits in speed and sensitivity. (retrospectively registered): ChiCTR1900023727. Registrated 9 JUNE 2019. Background Metagenomic next-generation sequencing (mNGS) is emerging as a promising technique for pathogens detection. However, reports on the application of mNGS in mixed pulmonary infection remain scarce. Methods From July 2018 to March 2019, 55 cases were enrolled in this retrospective analysis. Cases were classified into mixed pulmonary infection (36 [65.5%]) and non-mixed pulmonary infection (19 [34.5%]) according to primary diagnoses. The performances of mNGS and conventional test on mixed pulmonary infection diagnosis and pathogen identification were compared. Results The sensitivity of mNGS in mixed pulmonary infection diagnosis was much higher than that of conventional test (97.2% vs 13.9%; P < 0.01), but the specificity was the opposite (63.2% vs 94.7%; P = 0.07). The positive predictive value of mNGS was 83.3% (95% CI, 68.0-92.5%), and the negative predictive value was 92.3% (95% CI, 62.1-99.6%). A total of 5 (9.1%) cases were identified as mixed pulmonary infection by both conventional tests and mNGS, however, the pathogens identification results were consistent between these two methods in only 1 (1.8%) case. In summary, the pathogens detected by mNGS in 3 (5.5%) cases were consistent with those by conventional test, and only 1 (1.8%) case was mixed pulmonary infection. According to our data, mNGS had a broader spectrum for pathogen detection than conventional tests. In particular, application of mNGS improved the diagnosis of pulmonary fungal infections. Within the 55 cases, mNGS detected and identified fungi in 31 (56.4%) cases, of which only 10 (18.2%) cases were positive for the same fungi by conventional test. The most common pathogen detected by mNGS was Human cytomegalovirus in our study, which was identified in 19 (34.5%) cases of mixed pulmonary infection. Human cytomegalovirus and Pneumocystis jirovecii, which were detected in 7 (12.7%) cases, were the most common co-pathogens in the group of mixed pulmonary infection. Conclusions mNGS is a promising technique to detect co-pathogens in mixed pulmonary infection, with potential benefits in speed and sensitivity. Trial registration (retrospectively registered): ChiCTR1900023727. Registrated 9 JUNE 2019. Keywords: mNGS, Diagnosis, Mixed pulmonary infection Metagenomic next-generation sequencing (mNGS) is emerging as a promising technique for pathogens detection. However, reports on the application of mNGS in mixed pulmonary infection remain scarce. From July 2018 to March 2019, 55 cases were enrolled in this retrospective analysis. Cases were classified into mixed pulmonary infection (36 [65.5%]) and non-mixed pulmonary infection (19 [34.5%]) according to primary diagnoses. The performances of mNGS and conventional test on mixed pulmonary infection diagnosis and pathogen identification were compared. The sensitivity of mNGS in mixed pulmonary infection diagnosis was much higher than that of conventional test (97.2% vs 13.9%; P < 0.01), but the specificity was the opposite (63.2% vs 94.7%; P = 0.07). The positive predictive value of mNGS was 83.3% (95% CI, 68.0-92.5%), and the negative predictive value was 92.3% (95% CI, 62.1-99.6%). A total of 5 (9.1%) cases were identified as mixed pulmonary infection by both conventional tests and mNGS, however, the pathogens identification results were consistent between these two methods in only 1 (1.8%) case. In summary, the pathogens detected by mNGS in 3 (5.5%) cases were consistent with those by conventional test, and only 1 (1.8%) case was mixed pulmonary infection. According to our data, mNGS had a broader spectrum for pathogen detection than conventional tests. In particular, application of mNGS improved the diagnosis of pulmonary fungal infections. Within the 55 cases, mNGS detected and identified fungi in 31 (56.4%) cases, of which only 10 (18.2%) cases were positive for the same fungi by conventional test. The most common pathogen detected by mNGS was Human cytomegalovirus in our study, which was identified in 19 (34.5%) cases of mixed pulmonary infection. Human cytomegalovirus and Pneumocystis jirovecii, which were detected in 7 (12.7%) cases, were the most common co-pathogens in the group of mixed pulmonary infection. mNGS is a promising technique to detect co-pathogens in mixed pulmonary infection, with potential benefits in speed and sensitivity. Metagenomic next-generation sequencing (mNGS) is emerging as a promising technique for pathogens detection. However, reports on the application of mNGS in mixed pulmonary infection remain scarce.BACKGROUNDMetagenomic next-generation sequencing (mNGS) is emerging as a promising technique for pathogens detection. However, reports on the application of mNGS in mixed pulmonary infection remain scarce.From July 2018 to March 2019, 55 cases were enrolled in this retrospective analysis. Cases were classified into mixed pulmonary infection (36 [65.5%]) and non-mixed pulmonary infection (19 [34.5%]) according to primary diagnoses. The performances of mNGS and conventional test on mixed pulmonary infection diagnosis and pathogen identification were compared.METHODSFrom July 2018 to March 2019, 55 cases were enrolled in this retrospective analysis. Cases were classified into mixed pulmonary infection (36 [65.5%]) and non-mixed pulmonary infection (19 [34.5%]) according to primary diagnoses. The performances of mNGS and conventional test on mixed pulmonary infection diagnosis and pathogen identification were compared.The sensitivity of mNGS in mixed pulmonary infection diagnosis was much higher than that of conventional test (97.2% vs 13.9%; P < 0.01), but the specificity was the opposite (63.2% vs 94.7%; P = 0.07). The positive predictive value of mNGS was 83.3% (95% CI, 68.0-92.5%), and the negative predictive value was 92.3% (95% CI, 62.1-99.6%). A total of 5 (9.1%) cases were identified as mixed pulmonary infection by both conventional tests and mNGS, however, the pathogens identification results were consistent between these two methods in only 1 (1.8%) case. In summary, the pathogens detected by mNGS in 3 (5.5%) cases were consistent with those by conventional test, and only 1 (1.8%) case was mixed pulmonary infection. According to our data, mNGS had a broader spectrum for pathogen detection than conventional tests. In particular, application of mNGS improved the diagnosis of pulmonary fungal infections. Within the 55 cases, mNGS detected and identified fungi in 31 (56.4%) cases, of which only 10 (18.2%) cases were positive for the same fungi by conventional test. The most common pathogen detected by mNGS was Human cytomegalovirus in our study, which was identified in 19 (34.5%) cases of mixed pulmonary infection. Human cytomegalovirus and Pneumocystis jirovecii, which were detected in 7 (12.7%) cases, were the most common co-pathogens in the group of mixed pulmonary infection.RESULTSThe sensitivity of mNGS in mixed pulmonary infection diagnosis was much higher than that of conventional test (97.2% vs 13.9%; P < 0.01), but the specificity was the opposite (63.2% vs 94.7%; P = 0.07). The positive predictive value of mNGS was 83.3% (95% CI, 68.0-92.5%), and the negative predictive value was 92.3% (95% CI, 62.1-99.6%). A total of 5 (9.1%) cases were identified as mixed pulmonary infection by both conventional tests and mNGS, however, the pathogens identification results were consistent between these two methods in only 1 (1.8%) case. In summary, the pathogens detected by mNGS in 3 (5.5%) cases were consistent with those by conventional test, and only 1 (1.8%) case was mixed pulmonary infection. According to our data, mNGS had a broader spectrum for pathogen detection than conventional tests. In particular, application of mNGS improved the diagnosis of pulmonary fungal infections. Within the 55 cases, mNGS detected and identified fungi in 31 (56.4%) cases, of which only 10 (18.2%) cases were positive for the same fungi by conventional test. The most common pathogen detected by mNGS was Human cytomegalovirus in our study, which was identified in 19 (34.5%) cases of mixed pulmonary infection. Human cytomegalovirus and Pneumocystis jirovecii, which were detected in 7 (12.7%) cases, were the most common co-pathogens in the group of mixed pulmonary infection.mNGS is a promising technique to detect co-pathogens in mixed pulmonary infection, with potential benefits in speed and sensitivity.CONCLUSIONSmNGS is a promising technique to detect co-pathogens in mixed pulmonary infection, with potential benefits in speed and sensitivity.(retrospectively registered): ChiCTR1900023727. Registrated 9 JUNE 2019.TRIAL REGISTRATION(retrospectively registered): ChiCTR1900023727. Registrated 9 JUNE 2019. |
| ArticleNumber | 252 |
| Audience | Academic |
| Author | Wang, Jiahui Han, Yelei Feng, Jing |
| Author_xml | – sequence: 1 givenname: Jiahui surname: Wang fullname: Wang, Jiahui – sequence: 2 givenname: Yelei surname: Han fullname: Han, Yelei – sequence: 3 givenname: Jing orcidid: 0000-0003-0604-3581 surname: Feng fullname: Feng, Jing |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31856779$$D View this record in MEDLINE/PubMed |
| BookMark | eNp1Uktv1DAQjlARfcAP4IIiceGS4vEzuSBVFY9KBS5wtrzOOHiV2Iudrcq_x9ltoVuBfLBn_M03r--0OgoxYFW9BHIO0Mq3GWjbkYZA1wChtOFPqhPgChrKpTx68D6uTnNeEwKqFexZdcygFVKp7qT68hlnM2CIk7d1wNu5KQYmM_sY6ow_txisD0PtYqonf4t9vdmOUwwm_ap9cGh3wN6bIcTs8_PqqTNjxhd391n1_cP7b5efmuuvH68uL64bKySZGyM5CNcqYUSLVlnWWcZhVUxgHViwhjLCDQUmuFsBEMcUcz0jFB0XKNhZdbXn7aNZ603yUylIR-P1zhHToE2avR1RW0qXDAqJ5ZysVkYJRGdd71rWcUEL17s912a7mrC3GOZkxgPSw5_gf-gh3mjZURBqKebNHUGKZWB51pPPFsfRBIzbrCmjnWJl9qxAXz-CruM2hTKqBdV2kjDZ_UUNpjRQxhxLXruQ6gsJpGxPtkvd5_9AldNjWWZRivPFfxDw6mGjfzq8V0MBqD3ApphzQqetn3dSKMx-1ED0oju9150uutOL7jQvkfAo8p78_zG_AW-72Qw |
| CitedBy_id | crossref_primary_10_3389_fcimb_2023_1112229 crossref_primary_10_1186_s12941_022_00545_z crossref_primary_10_3389_fcimb_2024_1456407 crossref_primary_10_3389_fmicb_2024_1357372 crossref_primary_10_3390_ijms24065596 crossref_primary_10_3892_br_2021_1497 crossref_primary_10_3389_fcimb_2024_1398152 crossref_primary_10_3389_fcimb_2024_1439472 crossref_primary_10_12998_wjcc_v10_i5_1716 crossref_primary_10_3389_fcimb_2022_961746 crossref_primary_10_1007_s11096_024_01704_2 crossref_primary_10_3389_fcimb_2022_929856 crossref_primary_10_3390_microorganisms13030602 crossref_primary_10_1177_20499361241252537 crossref_primary_10_3389_fmed_2022_812005 crossref_primary_10_3389_fcimb_2023_1184245 crossref_primary_10_3389_fcimb_2023_1291980 crossref_primary_10_1128_spectrum_03791_23 crossref_primary_10_1186_s12941_024_00749_5 crossref_primary_10_3389_fcimb_2024_1458316 crossref_primary_10_1097_MD_0000000000036745 crossref_primary_10_3389_fcimb_2022_1026739 crossref_primary_10_3389_fcimb_2023_1106859 crossref_primary_10_1186_s12890_024_03135_1 crossref_primary_10_1186_s12890_022_02300_8 crossref_primary_10_3389_fcimb_2024_1367885 crossref_primary_10_1002_ctd2_12 crossref_primary_10_2147_IDR_S304569 crossref_primary_10_1093_ofid_ofad425 crossref_primary_10_2147_IDR_S416040 crossref_primary_10_3389_fcimb_2021_749905 crossref_primary_10_1002_jmv_28753 crossref_primary_10_3390_microorganisms9112309 crossref_primary_10_1080_21655979_2021_1911203 crossref_primary_10_1186_s12887_023_04199_4 crossref_primary_10_1186_s12931_024_02887_y crossref_primary_10_1186_s12890_023_02441_4 crossref_primary_10_3389_fped_2023_1183601 crossref_primary_10_1016_j_idcr_2023_e01758 crossref_primary_10_2147_IDR_S292768 crossref_primary_10_1186_s12879_023_08052_y crossref_primary_10_1186_s13027_023_00556_1 crossref_primary_10_3389_fmed_2023_1161661 crossref_primary_10_3389_fcimb_2021_661589 crossref_primary_10_1016_j_jtct_2023_01_024 crossref_primary_10_3389_fcimb_2023_1209724 crossref_primary_10_1128_spectrum_02190_21 crossref_primary_10_1186_s12941_023_00663_2 crossref_primary_10_2147_IDR_S387134 crossref_primary_10_3389_fmed_2021_736064 crossref_primary_10_3389_fcimb_2022_865637 crossref_primary_10_2147_IDR_S483156 crossref_primary_10_3389_fcimb_2022_894678 crossref_primary_10_1186_s13073_021_00991_y crossref_primary_10_3389_fcimb_2023_1271952 crossref_primary_10_3389_fcimb_2022_969126 crossref_primary_10_3389_fmed_2024_1483027 crossref_primary_10_1515_labmed_2023_0158 crossref_primary_10_1016_j_diagmicrobio_2023_116165 crossref_primary_10_2147_IDR_S385925 crossref_primary_10_1016_j_diagmicrobio_2024_116620 crossref_primary_10_1007_s40121_021_00482_y crossref_primary_10_3389_fcimb_2022_922996 crossref_primary_10_1002_advs_202405087 crossref_primary_10_1016_j_jare_2021_09_012 crossref_primary_10_3389_fcimb_2022_877205 crossref_primary_10_1016_j_heliyon_2024_e32816 crossref_primary_10_12677_ACM_2023_13102255 crossref_primary_10_3389_fcimb_2022_875822 crossref_primary_10_1007_s10096_021_04254_x crossref_primary_10_3390_jcm12051838 crossref_primary_10_1038_s41598_024_67174_8 crossref_primary_10_3389_fcimb_2021_694756 crossref_primary_10_2147_IDR_S333818 crossref_primary_10_1016_j_jiac_2025_102683 crossref_primary_10_1016_j_mimet_2024_107021 crossref_primary_10_2174_0113892010246350231030042340 crossref_primary_10_3389_fphar_2023_1164633 crossref_primary_10_1155_2021_7238495 crossref_primary_10_1128_jcm_00526_22 crossref_primary_10_1186_s12890_024_03473_0 crossref_primary_10_1093_ofid_ofad631 crossref_primary_10_1007_s15010_023_02148_y crossref_primary_10_12998_wjcc_v11_i4_866 crossref_primary_10_1016_j_rmcr_2024_102007 crossref_primary_10_2147_IDR_S401707 crossref_primary_10_3389_fmed_2022_952636 crossref_primary_10_1128_spectrum_03812_22 crossref_primary_10_1016_j_mimet_2023_106848 crossref_primary_10_1002_smtd_202000792 crossref_primary_10_3390_jof7080636 crossref_primary_10_1155_2021_9970817 crossref_primary_10_2147_IDR_S370964 crossref_primary_10_1186_s12967_022_03397_5 crossref_primary_10_3389_fcimb_2024_1395239 crossref_primary_10_1186_s12902_025_01837_z crossref_primary_10_1186_s12931_023_02654_5 crossref_primary_10_1016_j_ijid_2022_07_054 crossref_primary_10_1097_MD_0000000000026842 crossref_primary_10_1016_j_wneu_2025_123824 crossref_primary_10_2147_IDR_S365757 crossref_primary_10_3389_fcimb_2023_1228631 crossref_primary_10_2147_IJGM_S437800 crossref_primary_10_1080_23744235_2023_2276785 crossref_primary_10_1186_s12879_023_08376_9 crossref_primary_10_1186_s12879_022_07381_8 crossref_primary_10_3390_ijms23052769 crossref_primary_10_1128_spectrum_00746_22 crossref_primary_10_1016_j_rmcr_2023_101849 crossref_primary_10_1186_s12929_023_00926_2 crossref_primary_10_3389_fcimb_2022_950531 crossref_primary_10_3390_life12010007 crossref_primary_10_33073_pjm_2024_007 crossref_primary_10_1186_s12879_025_10806_9 crossref_primary_10_1016_j_jinf_2021_01_029 crossref_primary_10_1016_j_ijid_2022_07_060 crossref_primary_10_1186_s12890_021_01723_z crossref_primary_10_1016_j_ijid_2022_07_061 crossref_primary_10_3389_fcimb_2024_1457639 crossref_primary_10_1007_s10792_023_02665_7 crossref_primary_10_1080_14737159_2024_2436396 crossref_primary_10_1038_s41598_022_25314_y crossref_primary_10_1186_s12941_023_00608_9 crossref_primary_10_1007_s40121_021_00476_w crossref_primary_10_1016_j_jtct_2024_08_014 crossref_primary_10_3389_fmicb_2024_1295184 crossref_primary_10_3390_jof8111167 crossref_primary_10_1007_s15010_024_02185_1 crossref_primary_10_3389_fmicb_2020_599756 crossref_primary_10_12677_MD_2022_123039 crossref_primary_10_3389_fmicb_2022_1055996 crossref_primary_10_3390_jof8050480 crossref_primary_10_3389_fcimb_2024_1423541 crossref_primary_10_3389_fmed_2025_1567484 crossref_primary_10_1177_11206721221149077 crossref_primary_10_12677_ACM_2022_122176 crossref_primary_10_1016_j_heliyon_2024_e35287 crossref_primary_10_3389_fped_2022_1067634 crossref_primary_10_3389_fmed_2021_653294 crossref_primary_10_1093_ofid_ofad442 crossref_primary_10_3389_fmed_2024_1440130 crossref_primary_10_2147_IDR_S441083 crossref_primary_10_3389_fcimb_2023_1269853 crossref_primary_10_1186_s12931_022_02230_3 crossref_primary_10_3389_fcimb_2023_1136588 crossref_primary_10_1128_spectrum_00458_24 crossref_primary_10_2147_IDR_S394265 crossref_primary_10_3390_jof10070447 crossref_primary_10_1016_j_heliyon_2024_e30712 crossref_primary_10_3389_fpubh_2022_927338 crossref_primary_10_12677_ACM_2023_131066 crossref_primary_10_3389_fmed_2022_807174 crossref_primary_10_2147_IDR_S257587 crossref_primary_10_2147_IDR_S364241 |
| Cites_doi | 10.1097/CCM.0b013e31819ffea6 10.1093/cid/ciw444 10.3389/fcimb.2018.00205 10.1056/NEJM199001183220304 10.1128/JCM.01678-14 10.1161/01.CIR.0000084505.54603.C7 10.1128/mBio.01186-14 10.1177/1060028016650107 10.1146/annurev-pathmechdis-012418-012751 10.3201/eid1903.121151 10.1093/cid/ciy693 10.1086/588660 10.1378/chest.09-1652 10.1073/pnas.96.5.2402 10.1002/rmv.664 10.1007/s13365-015-0390-7 10.1002/JLB.2AB0418-158RR 10.1093/bioinformatics/btp324 10.1056/NEJMoa1306801 10.1056/NEJMoa1500245 10.1016/j.ijid.2019.01.034 10.1007/s15010-016-0873-3 |
| ContentType | Journal Article |
| Copyright | COPYRIGHT 2019 BioMed Central Ltd. 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s). 2019 |
| Copyright_xml | – notice: COPYRIGHT 2019 BioMed Central Ltd. – notice: 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s). 2019 |
| DBID | AAYXX CITATION NPM 3V. 7TO 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH H94 K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
| DOI | 10.1186/s12890-019-1022-4 |
| DatabaseName | CrossRef PubMed ProQuest Central (Corporate) Oncogenes and Growth Factors Abstracts Health & Medical Collection (ProQuest) ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials - QC ProQuest Central ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database ProQuest Central Premium ProQuest One Academic (New) ProQuest Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef PubMed Publicly Available Content Database Oncogenes and Growth Factors Abstracts ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | Publicly Available Content Database PubMed MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1471-2466 |
| EndPage | 8 |
| ExternalDocumentID | oai_doaj_org_article_c22c7c37e0c440bba75eefcfdf839452 PMC6921575 A610318682 31856779 10_1186_s12890_019_1022_4 |
| Genre | Journal Article |
| GrantInformation_xml | – fundername: National Natural Science Foundation of China grantid: 81970083, 81570084 and 81270144 – fundername: ; grantid: 81970083, 81570084 and 81270144 |
| GroupedDBID | --- 0R~ 23N 2WC 53G 5GY 5VS 6J9 6PF 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAWTL AAYXX ABUWG ACGFO ACGFS ACIHN ACPRK ADBBV ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CITATION CS3 DIK DU5 E3Z EBD EBLON EBS EJD EMB EMOBN F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR INH INR ITC KQ8 M1P M48 M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RBZ RNS ROL RPM RSV SMD SOJ SV3 TR2 UKHRP W2D WOQ WOW XSB -A0 3V. ACRMQ ADINQ C24 NPM PMFND 7TO 7XB 8FK AZQEC DWQXO H94 K9. PJZUB PKEHL PPXIY PQEST PQUKI PRINS 7X8 5PM PUEGO |
| ID | FETCH-LOGICAL-c560t-a6415f875a58ec7c39c341b5a51391c1ca2304a21354fb110f373fd302ef45e53 |
| IEDL.DBID | M48 |
| ISSN | 1471-2466 |
| IngestDate | Wed Aug 27 01:24:26 EDT 2025 Thu Aug 21 18:33:18 EDT 2025 Fri Jul 11 09:53:45 EDT 2025 Fri Jul 25 03:51:58 EDT 2025 Tue Jun 17 21:46:35 EDT 2025 Tue Jun 10 20:50:07 EDT 2025 Thu Jan 02 22:59:35 EST 2025 Thu Apr 24 23:07:03 EDT 2025 Tue Jul 01 02:40:21 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Mixed pulmonary infection Diagnosis mNGS |
| Language | English |
| License | Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c560t-a6415f875a58ec7c39c341b5a51391c1ca2304a21354fb110f373fd302ef45e53 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0000-0003-0604-3581 |
| OpenAccessLink | https://www.proquest.com/docview/2328960369?pq-origsite=%requestingapplication% |
| PMID | 31856779 |
| PQID | 2328960369 |
| PQPubID | 44785 |
| PageCount | 8 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_c22c7c37e0c440bba75eefcfdf839452 pubmedcentral_primary_oai_pubmedcentral_nih_gov_6921575 proquest_miscellaneous_2329731783 proquest_journals_2328960369 gale_infotracmisc_A610318682 gale_infotracacademiconefile_A610318682 pubmed_primary_31856779 crossref_citationtrail_10_1186_s12890_019_1022_4 crossref_primary_10_1186_s12890_019_1022_4 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2019-12-19 |
| PublicationDateYYYYMMDD | 2019-12-19 |
| PublicationDate_xml | – month: 12 year: 2019 text: 2019-12-19 day: 19 |
| PublicationDecade | 2010 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: London |
| PublicationTitle | BMC pulmonary medicine |
| PublicationTitleAlternate | BMC Pulm Med |
| PublicationYear | 2019 |
| Publisher | BioMed Central Ltd BioMed Central BMC |
| Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
| References | LJ Avino (1022_CR19) 2016; 50 AJ Labelle (1022_CR4) 2010; 137 J Wang (1022_CR9) 2019; 81 MJ Huang (1022_CR24) 2007; 25 TF Patterson (1022_CR12) 2016; 63 J Phair (1022_CR18) 1990; 322 E Hardak (1022_CR2) 2016; 44 C Grahame-Clarke (1022_CR16) 2003; 108 1022_CR14 AP Limaye (1022_CR17) 2010; 20 SS Magill (1022_CR1) 2014; 370 B De Pauw (1022_CR10) 2008; 46 H Guan (1022_CR11) 2016; 22 A Sobolewska (1022_CR23) 2009; 55 H Li (1022_CR7) 2018; 8 I Toma (1022_CR13) 2014; 52 W Gu (1022_CR5) 2019; 14 S Merali (1022_CR22) 1999; 96 1022_CR21 H Li (1022_CR8) 2009; 25 L Chiche (1022_CR15) 2009; 37 R Maini (1022_CR20) 2013; 19 S Jain (1022_CR3) 2015; 373 Q Miao (1022_CR6) 2018; 67 |
| References_xml | – volume: 37 start-page: 1850 issue: 6 year: 2009 ident: 1022_CR15 publication-title: Crit Care Med doi: 10.1097/CCM.0b013e31819ffea6 – volume: 63 start-page: 433 issue: 4 year: 2016 ident: 1022_CR12 publication-title: Clin Infect Dis doi: 10.1093/cid/ciw444 – volume: 8 start-page: 205 year: 2018 ident: 1022_CR7 publication-title: Front Cell Infect Microbiol doi: 10.3389/fcimb.2018.00205 – volume: 322 start-page: 161 issue: 3 year: 1990 ident: 1022_CR18 publication-title: N Engl J Med doi: 10.1056/NEJM199001183220304 – volume: 52 start-page: 3913 issue: 11 year: 2014 ident: 1022_CR13 publication-title: J Clin Microbiol doi: 10.1128/JCM.01678-14 – volume: 108 start-page: 678 issue: 6 year: 2003 ident: 1022_CR16 publication-title: Circ doi: 10.1161/01.CIR.0000084505.54603.C7 – ident: 1022_CR21 doi: 10.1128/mBio.01186-14 – volume: 50 start-page: 673 issue: 8 year: 2016 ident: 1022_CR19 publication-title: Ann Pharmacother doi: 10.1177/1060028016650107 – volume: 14 start-page: 319 year: 2019 ident: 1022_CR5 publication-title: Annu Rev Pathol doi: 10.1146/annurev-pathmechdis-012418-012751 – volume: 19 start-page: 386 issue: 3 year: 2013 ident: 1022_CR20 publication-title: Emerg Infect Dis doi: 10.3201/eid1903.121151 – volume: 55 start-page: 451 issue: 4 year: 2009 ident: 1022_CR23 publication-title: Wiad Parazytol – volume: 67 start-page: S231 issue: suppl_2 year: 2018 ident: 1022_CR6 publication-title: Clin Infect Dis doi: 10.1093/cid/ciy693 – volume: 46 start-page: 1813 issue: 12 year: 2008 ident: 1022_CR10 publication-title: Clin Infect Dis doi: 10.1086/588660 – volume: 137 start-page: 1130 issue: 5 year: 2010 ident: 1022_CR4 publication-title: Chest doi: 10.1378/chest.09-1652 – volume: 96 start-page: 2402 issue: 5 year: 1999 ident: 1022_CR22 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.96.5.2402 – volume: 20 start-page: 372 issue: 6 year: 2010 ident: 1022_CR17 publication-title: Rev Med Virol doi: 10.1002/rmv.664 – volume: 22 start-page: 240 issue: 2 year: 2016 ident: 1022_CR11 publication-title: J Neurovirol doi: 10.1007/s13365-015-0390-7 – volume: 25 start-page: 129 issue: 2 year: 2007 ident: 1022_CR24 publication-title: Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi – ident: 1022_CR14 doi: 10.1002/JLB.2AB0418-158RR – volume: 25 start-page: 1754 issue: 14 year: 2009 ident: 1022_CR8 publication-title: Bioinform (Oxford, Engl) doi: 10.1093/bioinformatics/btp324 – volume: 370 start-page: 1198 issue: 13 year: 2014 ident: 1022_CR1 publication-title: N Engl J Med doi: 10.1056/NEJMoa1306801 – volume: 373 start-page: 415 issue: 5 year: 2015 ident: 1022_CR3 publication-title: N Engl J Med doi: 10.1056/NEJMoa1500245 – volume: 81 start-page: 123 year: 2019 ident: 1022_CR9 publication-title: Int J Infect Dis doi: 10.1016/j.ijid.2019.01.034 – volume: 44 start-page: 491 issue: 4 year: 2016 ident: 1022_CR2 publication-title: Infect doi: 10.1007/s15010-016-0873-3 |
| SSID | ssj0017853 |
| Score | 2.5776873 |
| Snippet | Metagenomic next-generation sequencing (mNGS) is emerging as a promising technique for pathogens detection. However, reports on the application of mNGS in... Background Metagenomic next-generation sequencing (mNGS) is emerging as a promising technique for pathogens detection. However, reports on the application of... Abstract Background Metagenomic next-generation sequencing (mNGS) is emerging as a promising technique for pathogens detection. However, reports on the... |
| SourceID | doaj pubmedcentral proquest gale pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | 252 |
| SubjectTerms | Analysis Anemia Antibiotics Bacteria Biopsy Cytomegalovirus Cytomegalovirus infections Deoxyribonucleic acid Diagnosis Diagnostic tests DNA Fungi Health aspects Histopathology Infection Infections Laboratories Leukemia Lung diseases Medical tests Mixed pulmonary infection mNGS Mycoses Next-generation sequencing Pathogenic microorganisms Pathogens Patients Pneumonia Pulmonology Retirement benefits Software Tuberculosis |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3daxQxEA_SB_FFrJ9rq0QQBCF0N9_7WMVShOuThb6FJJvoQbstvTvQ_96ZbO64RdAXH3czgc3szP7ml8zOEPIeMMbnYD3TbQKCkkJkvR8EAzAfAKCVNQk39BcX-vxSfr1SV3utvjAnbCoPPCnuJHIeTRQmtVHKNgRvVEo55iEDtEtVvr6AeVsyVc8PDKBQPcPsrD5ZdXieBrS5Z8hwmJyhUCnW_-cneQ-T5vmSewB09oQ8rpEjPZ2e-JA8SONT8nBRz8afkYtFWnssuXqzjHREQvu9lJRGzdOaMQ04RSFKpTfLn2mgd5trMEJ__4tuU7JGOkypd8vVc3J59uXb53NWuyWwCFHLmnkNWJyBfnhlE6qsj4BQAS4hyOtiFz3u_3reCSVzANTPwog8iJanLFVS4gU5GG_H9IrQAKzGSm78kKOMIQEn84KbkDpvfeS5Ie1Wey7WUuLY0eLaFUphtZsU7kDhDhXuZEM-7qbcTXU0_ib8CV_JThBLYJcbYBiuGob7l2E05AO-UIeOCg8Xff3fAJaIJa_cqcYOF1ZbkDyeSYKDxfnw1iRcdfCVg0DUAvkTum_Iu90wzsSktTHdbooMNgYzVjTk5WRBuyXhT-vaGJhtZrY1W_N8ZFz-KOW_dQ9hmlGv_4eSjsgjXryCs64_Jgfr-016A1HWOrwtDvUb0l8lQQ priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection (ProQuest) dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9wwDDdbB2MvY9_N1o0MBoOBaeLvPI1urJTB9WmFezO2Y3cHbe52H9D-95MSX9Yw6GNiGSJZ8k-yFYmQT4AxLnnjqKoiBCjRB9q4llMA8xYAWhod8UB_dq7OLsTPuZznA7dNTqvc74n9Rt0uA56RHwPyG_C2uWq-rv5Q7BqFt6u5hcZD8ghLl2FKl56PARc2nuf5JrM26nhT460aBM8NxTiHigkW9SX7_9-Y7yDTNGvyDgydPiNPs_9YngwL_pw8iN0L8niWb8hfkvNZ3DosvHq9CGWHYe1lX1ga5V_mvGlAqxJ81fJ6cRPbcrW7At7c-rbcJ2Z1ZTsk4C02r8jF6Y9f389o7plAA_guW-oUIHKCIMRJE4MOvAmAUx4ewdWrQx0cngI7VnMpkgfsT1zz1PKKxSRklPw1OeiWXTwkpYfYxgimXZuCCD5CZOY40z7WzrjAUkGqvfRsyAXFsa_Fle0DC6PsIHALArcocCsK8mWcshqqadxH_A2XZCTEQtj9i-X60ma7soEx5FLHKghRee-0jDGF1Cbw_IRkBfmMC2rRXOHjgst_HQCLWPjKnijsc2GUAcqjCSWYWZgO71XCZjPf2H9KWZCP4zDOxNS1Li53PQ22B9OGF-TNoEEjS_jrutIaZuuJbk14no50i999EXDVgLOm5dv7P-sdecJ6fWe0bo7IwXa9i-_Bi9r6D72p_AUV9Rua priority: 102 providerName: ProQuest |
| Title | Metagenomic next-generation sequencing for mixed pulmonary infection diagnosis |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/31856779 https://www.proquest.com/docview/2328960369 https://www.proquest.com/docview/2329731783 https://pubmed.ncbi.nlm.nih.gov/PMC6921575 https://doaj.org/article/c22c7c37e0c440bba75eefcfdf839452 |
| Volume | 19 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3ra9swED_6gNIvY-9564IHg8HAW2zJkvxhjHa0lEHCGAvkm5BkqQukTpcHtP_97vzIYtbtY6xTiE53-d1POt8BvEWMMcEqk4ihR4LirUsKU7IEwbxEgM6V9HSgPxqLywn_Os2ne9C1t2oVuLqX2lE_qcly_uH2191ndPhPtcMr8XGV0m0ZkuIiIf6S8H04RGCS5Kcj_udSQSI0tReb9047hiN6l1hIyuvaQam6mP_ff9k7mNXPp9wBqIuH8KCNLOPTxhQewZ6vHsPRqL07fwLjkV8bKsl6PXNxRYT3qi45TTsTtxnViGMxRrHx9ezWl_HNZo5GapZ3cZeyVcVlk5o3Wz2FycX5jy-XSdtNIXEY1awTIxCrA9ITkyvvpGOFQwSz-BGDwNSlztD5sMlSlvNgMSoITLJQsmHmA899zp7BQbWo_AuILbIexTNpyuC4sx45m2GZtD41yrgsRDDstKddW2qcOl7MdU05lNCN7jXqXpPuNY_g_XbKTVNn43_CZ7QlW0EqkV0_WCyvdOtx2mUZrVL6oeN8aK2RuffBhTJgTMjzLIJ3tKGaTAt_nDPt-wi4RCqJpU8FdcBQQqHkSU8SHdD1hzuT0J39agxUFZJDJooI3myHaSYltVV-sallqHGYVCyC540FbZfUGWIEsmdbvTX3R6rZz7o8uCgwjJP5y39-5ys4zmqrz5K0OIGD9XLjX2NotbYD2JdTOYDDs_Pxt--D-oBiUDvRbxPdIeM |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3daxQxEA_lCuqL-O1q1QiKIITuZrOb7INIqy1X2ztEWuhbTLJJPWj3zvtA-0_5NzqzH2cXoW99vMsENpPJ_GYykxlC3gDGmGCVYXnswUHx1rHClCkDMC8BoDMlPV7oj8b58ER8Oc1ON8if7i0MplV2OrFW1OXU4R35NiC_Ams7zYuPs58Mu0ZhdLVrodGIxaG__AUu2-LDwWfY37ec7-8dfxqytqsAc4DuS2ZywKwAZrrJlHfSpYUDTW7hJxhDiUucwXtSw5M0E8ECOoZUpqFMY-6DyDx2iQCVvylScGUGZHN3b_z12zpuIQH92thpovLtRYJxPHDXC4aeFRM99KubBPwPBVewsJ-neQX49u-Ru63FSncaEbtPNnz1gNwatTH5h2Q88kuDpV4vJo5W6Eif1aWsccdpm6kN-EjBOqYXk9--pLPVOXDTzC9plwpW0bJJ-ZssHpGTG-HnYzKoppV_SqgFb0oJLk0ZnHDWgy9oUi6tT4wyjoeIxB33tGtLmGMnjXNduzIq1w3DNTBcI8O1iMj79ZRZU7_jOuJd3JI1IZberv-Yzs90e5K14xxXKX3shIitNTLzPrhQBrA1RcYj8g43VKOCgI9zpn3nAEvEUlt6J8fOGipXQLnVo4SD7frDnUjoVrEs9L9jEJHX62GciclylZ-uahpsSCZVGpEnjQStl4SP5XMpYbbsyVZvzf2RavKjLjueF2AeyuzZ9Z_1itweHo-O9NHB-PA5ucNr2ecsKbbIYDlf-Rdgwy3ty_bgUPL9ps_qX-7wWEM |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Metagenomic+next-generation+sequencing+for+mixed+pulmonary+infection+diagnosis&rft.jtitle=BMC+pulmonary+medicine&rft.au=Wang%2C+Jiahui&rft.au=Han%2C+Yelei&rft.au=Feng%2C+Jing&rft.date=2019-12-19&rft.eissn=1471-2466&rft.volume=19&rft.issue=1&rft.spage=252&rft_id=info:doi/10.1186%2Fs12890-019-1022-4&rft_id=info%3Apmid%2F31856779&rft.externalDocID=31856779 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2466&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2466&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2466&client=summon |